Ameriprise’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-309,250
| Closed | -$7.34M | – | 4024 |
|
|
2023
Q3 | $7.34M | Sell |
309,250
-65,133
| -17% | -$1.23M | ﹤0.01% | 1966 |
|
|
2023
Q2 | $6.07M | Buy |
374,383
+13,037
| +4% | +$216K | ﹤0.01% | 2190 |
|
|
2023
Q1 | $6.29M | Sell |
361,346
-19,945
| -5% | -$359K | ﹤0.01% | 2156 |
|
|
2022
Q4 | $7.16M | Sell |
381,291
-12,272
| -3% | -$236K | ﹤0.01% | 2034 |
|
|
2022
Q3 | $6.97M | Buy |
393,563
+51,170
| +15% | +$888K | ﹤0.01% | 1984 |
|
|
2022
Q2 | $5.97M | Sell |
342,393
-6,453
| -2% | -$123K | ﹤0.01% | 2143 |
|
|
2022
Q1 | $7.29M | Sell |
348,846
-9,095
| -3% | -$174K | ﹤0.01% | 2162 |
|
|
2021
Q4 | $6.37M | Buy |
357,941
+120,997
| +51% | +$1.94M | ﹤0.01% | 2302 |
|
|
2021
Q3 | $3.34M | Sell |
236,944
-3,472
| -1% | -$54K | ﹤0.01% | 2638 |
|
|
2021
Q2 | $3.99M | Sell |
240,416
-9,248
| -4% | -$166K | ﹤0.01% | 2603 |
|
|
2021
Q1 | $4.52M | Buy |
249,664
+13,171
| +6% | +$260K | ﹤0.01% | 2454 |
|
|
2020
Q4 | $4.31M | Sell |
236,493
-44,025
| -16% | -$698K | ﹤0.01% | 2372 |
|
|
2020
Q3 | $3.57M | Buy |
280,518
+51,565
| +23% | +$659K | ﹤0.01% | 2317 |
|
|
2020
Q2 | $2.51M | Sell |
228,953
-7,617
| -3% | -$78.9K | ﹤0.01% | 2489 |
|
|
2020
Q1 | $2.47M | Sell |
236,570
-33,720
| -12% | -$435K | ﹤0.01% | 2368 |
|
|
2019
Q4 | $4.34M | Sell |
270,290
-220
| -0.1% | -$3.63K | ﹤0.01% | 2320 |
|
|
2019
Q3 | $4.24M | Sell |
270,510
-11,675
| -4% | -$194K | ﹤0.01% | 2291 |
|
|
2019
Q2 | $5.62M | Sell |
282,185
-13,645
| -5% | -$255K | ﹤0.01% | 2175 |
|
|
2019
Q1 | $4.98M | Sell |
295,830
-4,645
| -2% | -$80.5K | ﹤0.01% | 2230 |
|
|
2018
Q4 | $4.55M | Sell |
300,475
-50,175
| -14% | -$861K | ﹤0.01% | 2176 |
|
|
2018
Q3 | $7.04M | Sell |
350,650
-21,846
| -6% | -$463K | ﹤0.01% | 2133 |
|
|
2018
Q2 | $7.26M | Buy |
372,496
+92,836
| +33% | +$1.47M | ﹤0.01% | 1980 |
|
|
2018
Q1 | $3.82M | Buy |
279,660
+3,430
| +1% | +$45.2K | ﹤0.01% | 2360 |
|
|
2017
Q4 | $3.75M | Buy |
276,230
+22,435
| +9% | +$322K | ﹤0.01% | 2314 |
|
|
2017
Q3 | $3.99M | Sell |
253,795
-33,914
| -12% | -$547K | ﹤0.01% | 2245 |
|
|
2017
Q2 | $4.95M | Buy |
287,709
+29,069
| +11% | +$442K | ﹤0.01% | 2077 |
|
|
2017
Q1 | $3.94M | Buy |
258,640
+11,712
| +5% | +$172K | ﹤0.01% | 2220 |
|
|
2016
Q4 | $3.25M | Buy |
246,928
+22,330
| +10% | +$286K | ﹤0.01% | 2371 |
|
|
2016
Q3 | $2.54M | Sell |
224,598
-28,320
| -11% | -$340K | ﹤0.01% | 2434 |
|
|
2016
Q2 | $3.01M | Buy |
252,918
+48,700
| +24% | +$655K | ﹤0.01% | 2295 |
|
|
2016
Q1 | $3.11M | Sell |
204,218
-2,050
| -1% | -$31.1K | ﹤0.01% | 2274 |
|
|
2015
Q4 | $3.32M | Sell |
206,268
-57,223
| -22% | -$835K | ﹤0.01% | 2306 |
|
|
2015
Q3 | $3.29M | Sell |
263,491
-398,995
| -60% | -$5.48M | ﹤0.01% | 2291 |
|
|
2015
Q2 | $11M | Buy |
662,486
+13,481
| +2% | +$217K | 0.01% | 1516 |
|
|
2015
Q1 | $10.4M | Buy |
649,005
+296,499
| +84% | +$4.9M | 0.01% | 1529 |
|
|
2014
Q4 | $5.5M | Buy |
352,506
+50,327
| +17% | +$736K | ﹤0.01% | 1991 |
|
|
2014
Q3 | $4.16M | Buy |
302,179
+115,840
| +62% | +$1.76M | ﹤0.01% | 2137 |
|
|
2014
Q2 | $2.99M | Sell |
186,339
-149,825
| -45% | -$2.37M | ﹤0.01% | 2355 |
|
|
2014
Q1 | $5.67M | Sell |
336,164
-29,874
| -8% | -$542K | ﹤0.01% | 1926 |
|
|
2013
Q4 | $7.71M | Sell |
366,038
-29,317
| -7% | -$660K | ﹤0.01% | 1691 |
|
|
2013
Q3 | $8.59M | Sell |
395,355
-15,820
| -4% | -$338K | 0.01% | 1571 |
|
|
2013
Q2 | $7.69M | Buy |
+411,175
| New | +$7.5M | 0.01% | 1602 |
|
Other funds holding NXGN
Ameriprise's NXGN Position: Q4 2023 in Review
Ameriprise sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 309,250 shares — an estimated $7.34M sold.
Ameriprise first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $11M in Q2 2015. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Ameriprise reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Ameriprise sold 309,250 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $7.34M.
- Ameriprise first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Ameriprise's NextGen Healthcare, Inc. Common Stock position peaked at $11M in Q2 2015.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Ameriprise's 13F filing for Q4 2023, filed 14 Feb 2024.